JohnAWellsIIIMDFACS

PubMed

• Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
  Wong, T., Haskova, Z., Asik, K., Baumal, C., Csaky, K., Eter, N., Ives, J., Jaffe, G., Korobelnik, J., Lin, H., Murata, T., Ruamviboonsuk, P., Schlottmann, P., Seres, ...> ;Ophthalmology. 2023 Dec 28
• 9 citations
  Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema.
  Arshad M Khanani, Sunil S Patel, Victor H Gonzalez, Suk J Moon, Glenn J Jaffe, John A Wells, Petra Kozma, Pravin U Dugel, Raj K Maturi> ;Ophthalmology Science. 2021 Sep 1
• 10 citations
  One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Ph...
  Jennifer K. Sun, Raj K. Maturi, David S. Boyer, John A. Wells, Victor H. Gonzalez, Robert Tansley, Helen Hernandez, Andreas Maetzel, Edward P. Feener, Lloyd Paul Aiello> ;Ophthalmology. Retina. 2019 Jul 26
• 28 citations
  Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
  Lee M. Jampol, Adam R. Glassman, Danni Liu, Lloyd Paul Aiello, Neil M. Bressler, Elia J. Duh, Susan E. Quaggin, John A. Wells, Charles C. Wykoff, David J. Browning, An...> ;Ophthalmology. 2018 Mar 7
• 51 citations
  Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement
  Norihiko Kamioka, John A. Wells, Patricia Keegan, Stamatios Lerakis, Jose N. Binongo, Frank Corrigan, Jose F. Condado, Ateet Patel, Jessica Forcillo, Leslie Ogburn, An...> ;JACC. Cardiovascular Interventions. 2018 Jan 22
• 111 citations
  Change in diabetic retinopathy through 2 years secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab
  Susan B. Bressler, Danni Liu, Adam R. Glassman, Barbara A Blodi, Alessandro A. Castellarin, Lee M. Jampol, Paul L. Kaufman, Michele Melia, Harinderjit Singh, John A. W...> ;JAMA Ophthalmology. 2017 Jun 1
• Reply.
  John A Wells, Adam R Glassman, Neil M Bressler, Allison R Ayala, Lee M Jampol> ;Ophthalmology. 2017 Apr 1
• Reply.
  John A Wells, Adam R Glassman, Lee M Jampol, Allison Ayala, Neil M Bressler> ;Ophthalmology. 2017 Mar 1
• Reply.
  John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol> ;Ophthalmology. 2017 Jan 1
• 33 citations
  Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial.
  Lee M. Jampol, Adam R. Glassman, Neil M. Bressler, John A. Wells, Allison R Ayala> ;JAMA Ophthalmology. 2016 Dec 1
• 612 citations
  Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
  John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Neil M. Bressler, Susan B. Bressler, Alexander J. Brucker, Frederick L. Ferris, G. Robert Hampton, Ch...> ;Ophthalmology. 2016 Jun 1
• 65 citations
  A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
  Glenn J. Jaffe, Dean Eliott, John A. Wells, Jonathan L. Prenner, András Papp, S. C. Patel> ;Ophthalmology. 2016 Jan 1
• Join now to see all

Journal Articles

• Factors Associated With Changes in Visual Acuity and Central Subfield Thickness at 1 Year After Treatment for Diabetic Macular Edema With Ranibizumab  
  Susan B. Bressler, MD; Haijing Qin, MS; Roy W. Beck, MD, PhD; Kakarla V. Chalam, MD; Judy E. Kim, MD; Michele Melia, ScM; John A. Wells III, MD; for the Diabetic Retin..., Arch Ophthalmol, 1/1/2012
• Expanded 2-year Follow-up of a Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema  
  The Diabetic Retinopathy Clinical Research Network, Ophthalmology, 4/1/2011
• Ranibizumab and Bevacizuamb for Neovascular Age-related Macular Degeneration  
  The CATT Research Group, N Engl J Med, 1/1/2011
• Factors Associated with Visual Acuity Outcomes after Vitrectomy for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Retina, 10/1/2010
• Vitrectomy Outcomes in Eyes with Diabetic Macular Edema and Vitreomacular Traction  
  Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net, Haller JA, Qin H, Apte RS, Beck RW, Bressler NM, Browning DJ, Danis RP, Gla..., Ophthalmology, 6/1/2010
• Randomized Trial Evaluating Ranibizumab plus Prompt or Deferred Laser or Triamcinolone plus Prompt Laser for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Ophthalmology, 6/1/2010
• Factors Associated with Improvement and Worsening of Visual Acuity 2 Years after Focal/grid Photocoagulation for Diabetic Macular Edema  
  Aiello LP, Edwards AR, Beck RW, Bressler NM, Davis MD, Ferris FL, Glassman AR, Ip MS, Miller KM, for the Diabetic Retinopathy Clinical Research Network, Ophthalmology, 5/11/2010
• Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion  
  Wroblewski JJ, Wells JA 3rd, Gonzales CR, Am J Ophthalmol, 1/1/2010
• Pegaptanib Sodium as Maintenanace Therapy in Neovascular Age-related Macular Degeneration  
  Friberg TR, Tolentino M for the LEVEL Study Group, Br J Ophthalmol, 1/1/2010
• The Risk of Endophthalmitis Following Intravitreal Injection in the DRCRnet Laser-Ranibizumab-Triamcinolone Clinical Trials  
  Bhavsar AR, Googe JM Jr, Stockdale CR, Bressler NM, Brucker AJ, Elman MJ, Glassman AR; Diabetic Retinopathy Clinical Research Network, Arch Ophthalmol, 12/1/2009
• The Course of Response to Focal/grid Photocoagulation for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Retina, 11/1/2009
• A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Cen...  
  The SCORE Study Research Group, Arch Ophthalmol, 9/1/2009
• A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to B...  
  The SCORE Study Research Group, Arch Ophthalmol, 9/1/2009
• Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion  
  Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM; Pegaptanib in Central Retinal Vein Occlusion Study Group, Arch Ophthalmol, 4/1/2009
• Association of the Extent of Diabetic Macular Edema as Assessed by Optical Coherence Tomography with Visual Acuity and Retinal Outcome Variables  
  Browning DJ, Apte RS, Bressler SB, Chalam KV, Danis RP, Davis MD, Kollman C, Qin H, Sadda S, Scott IU; Diabetic Retinopathy Clinical Research Network, Retina, 3/1/2009
• Three-year Follow up of a Randomized Trial Comparing Focal/grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network (DRCR.net), Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C, Arch Ophthalmol, 3/1/2009
• Observational Study of the Development of Diabetic Macular Edema following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings  
  Diabetic Retinopathy Clinical Research Network, Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA..., Arch Ophthalmol, 2/1/2009
• A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/grid Photocoagulation for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Ophthalmology, 9/1/2008
• Optical Coherence Tomography Measurements and Analysis Methods in Optical Coherence Tomography Studies of Diabetic Macular Edema  
  Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H; Diabetic Retino..., Ophthalmology, 8/1/2008
• A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/grid Photocoagulation for Diabetic Macular Edema: Baseline Features  
  Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H; Diabetic Retinopathy Clinical Research Network, Retina, 7/1/2008
• Retinal Thickness on Stratus Optical Coherence Tomography in People with Diabetes and Minimal or No Diabetic Retinopathy  
  Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK; D..., Am J Ophthalmol, 5/1/2008
• A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M..., Ophthalmology, 10/1/2007
• Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Laser Grid Photocoagulation Strategies for Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Arch Ophthalmol, 1/1/2007
• The Risk of Endophthalmitis following Intravitreal Injection in the DRCRnet and SCORE Clinical Trials  
  Diabetic Retinopathy Clinical Research Network, Am J Ophthalmol, 1/1/2007
• Relationship between Optical Coherence Tomography-measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema  
  Diabetic Retinopathy Clinical Research Network, Ophthalmology, 1/1/2007
• Join now to see all

Abstracts/Posters

• Factors Associated with Changes in Visual Acuity and OCT Thickness at One Year after Treatment with Ranibizumab for DME
  Wells JA for the Diabetic Retinopathy Clinical Research Network, 29th Annual Meeting of the American Society of Retina Specialists, Boston, MA, 8/22/2011
• Failure of Intravitreal Bevacizumab Therapy for Neovascular AMD Followed by Successful Response to Intravitreal Ranibizumab
  Katz B and Wells JA, ARVO Annual Meeting, Fort Lauderdale, FL, 5/1/2011
• Pegaptanib Sodium (Macugen) In the Treatment of Diabetic Macular Edema (DME): A Case Series from Two Clinical Practices
  Wells JA, Driver MC, Retina Congress 2009 New York: A Combined Meeting of the American Society of Retina Specialists, The Retina Society and the Macula Society, New York, NY, 10/1/2009
• Treatment of Diabetic Macular Edema (DME) With Pegaptanib Sodium (Macugen): A Case Series
  Wells III JA, Driver M, ARVO Annual Meeting, Fort Lauderdale, FL, 5/4/2009
• Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
  Wroblewski JJ, Wells JA, Gonzales C, ARVO Annual Meeting, Fort Lauderdale , FL, 4/29/2008
• Pegaptanib for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Interim Results of an Open Label Study
  Wroblewski JJ, Wells III JA, Gonzales CR, Clark WL, Schwartz SD, 25th Annual Meeting, American Society of Retinal Specialists Program Summary, Indian Wells, California, 12/3/2007
• Pegapatanib Sodium for the Treatment of Macular Edema following Central Retinal Vein Occlusion (CRVO): Functional Outcomes
  Wells III JA, Wroblewski JJ, for the Macugen in CRVO Study Group, ARVO Abstracts, 1/1/2007
• Safety and Efficacy of Pegaptanib Sodium in Treating Macular Edema Secondary to Central Retinal Vein Occlusion
  JA for the Pegaptanib in Central Retinal Vein Occlusion Study Group, American Academy of Ophthalmology Annual Meeting, Las Vegas, NV, 11/12/2006
• Tissue Plasminogen Activator (t-PA) Assisted Subfoveal Hemorrhage Displacement Surgery
  Boada R, Cady R, Wells JA, Clark WL, Goins C, Saperstein D, ARVO Abstracts, 5/1/2002
• Reticular Pseudodrusen in Age-related Macular Degeneration
  Wells JA, XXII Meeting of the Club Jules Gonin, Taormina, Sicily, 9/1/2000
• Incidence of Full-thickness Macular Holes in Fellow Eyes: A Prospective Five Year Study
  Wells JA, Ezra EM, Gregor ZJ, XXI Meeting of the Club Jules Gonin, 9/1/1998
• Diagnosing and Staging of Macular Holes Using Autofluorescence Imaging
  Gregor ZJ, Ruckmann AV, Schmidt KG, Wells J, ARVO Abstracts, 4/1/1996
• Macular Hole Surgery with and without Autologous Serum: A Prospective Study of 109 Consecutive Eyes
  Ezra E, Wells JA, Charteris DG, Aylward GW, Gregor ZJ, ARVO Abstracts, 4/1/1996
• Fellow Eye Macular Holes: Incidence and Risk Factors
  Wells JA, Grey RB, Arden GB, Gregor ZJ, American Academy of Ophthalmology Annual Meeting, Atlanta, 10/1/1995
• Vascular Endothelial Growth Factor/vascular Permeability Factor (VEGF/VPF) Levels Are Elevated in the Vitreous of Patients with Subretinal Neovascularization
  Wells JA, Chibber R, Kohner E, Gregor ZJ, ARVO Abstracts, 5/1/1995
• Trans-scleral Indirect Argon Laser Drainage of Subretinal Fluid
  Pitts JF, Schwartz SD, Wells JA, Gregor ZJ, The Royal College of Ophthalmologists Annual Meeting Abstracts, 5/1/1995
• Surgical Treatment of Full-thickness Macular Holes Using Autologous Serum
  Wells JA, Gregor ZJ, The Royal College of Ophthalmologists Annual Meeting Abstracts, 5/1/1995
• Trans-scleral Indirect Argon Laser Drainage of Subretinal Fluid
  Pitts JF, Schwartz SD, Wells JA, Gregor ZJ, The Royal College of Ophthalmologists Annual Meeting, Birmingham, 5/1/1995
• Fellow Eye Involvement in Patients with Macular Holes: Incidence and Identification of Eyes at Risk
  Wells JA, Gray RH, Kinsella F, Orr GM, Arden GB, Gregor ZJ, American Academy of Ophthalmology Annual Meeting, 1/1/1995
• Acute Zonal Occult Outer Retinopathy
  Wolin MJ, Wells JA, North American Neuro-ophthalmology Society Abstracts, 2/1/1994
• Bilateral Macular Drusen in Age-related Macular Degeneration: Prognosis and Risk Factors
  Holz FG, Wolfensberger TJ, Piguet B, Wells JA, et al., American Academy of Ophthalmology Annual Meeting, 1/1/1993
• Corneas from Ventilator Supported Donors: Endothelial Morphology and Results of a Survey
  Seedor JA, Walsh GE, Wells JA, et al., Eye Bank Association of America Abstracts, 11/1/1987
• Three Year Morphological Follow-up of Hydrogel Intracorneal Implants
  Wells JA, McCarey BE, ARVO Abstracts, 5/1/1987
• Three-year Morphological Follow-up of Hydrogel Intracorneal Implants
  Wells JA, McCarey BE, ARVO Annual Meeting, Sarasota, 5/1/1987
• A Phase 1 Dose Escalation Study of Intravitreal JSM6427, an Integrin Alpha5Beta1 Antagonist, in Neovascular AMD
  Wells III JA, Gonzalez VH, Heier JS, et al, American Academy of Ophthalmology 2008 Annual Meeting Program
• Join now to see all

Lectures

• Ranibizumab and Bevicizumab for Neovascular AMD. Age-Related Macular Degeneration: Fundamental Aspects and Translation into New Treatments 
  Baden-Baden, Germany - 9/8/2011
• Number of Laser-ranibizumab-triamcinolone Treatments for Diabetic Macular Edema 
  Kyoto, Japan - 11/6/2010
• DRCR Network Panel Discussion on Diabetic Macular Edema 
  Chicago, IL - 10/16/2010
• Number of Laser-ranibizumab-triamcinolone Treatments for Diabetic Macular Edema (DME) 
  Vancouver, BC, Canada - 8/29/2010
• Factors Associated with Improvement and Worsening of Visual Acuity 2 Years after Focal/grid Photocoagulation for Diabetic Macular Edema 
  San Francisco, CA - 10/25/2009
• A Phase 1 Open-label Study of Single and Repeated Doses of Intravitreal JSM6427, a Small Molecule Integrin Alpha5Beta1 Antagonist, in Neovascular Age-related Macular ... 
  Fort Lauderdale, FL - 5/4/2009
• A Phase 1 Dose Escalation Study of Intravitreal JSM6427, an Integrin Alpha5Beta1 Antagonist, in Neovascular AMD 
  Atlanta, GA - 11/11/2008
• A Phase 1 Open-label Study of Single and Repeated Doses of Intravitreal JSM6427, a Small Molecule Integrin Alpha5Beta1 Antagonist, in Neovascular Age-related Macular D... 
  St. Moritz, Switzerland - 9/11/2008
• Safety and Efficacy of Pegaptanib Sodium in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion 
  Indian Wells, California - 12/3/2007
• Pegaptanib for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Interim Results of an Open Label Study 
  Indian Wells, California - 12/3/2007
• American Academy of Ophthalmology Update 
  Sea Island, GA - 7/29/2007
• Pegapatanib Sodium for the Treatment of Macular Edema following Central Retinal Vein Occlusion (CRVO): Functional Outcomes 
  Fort Lauderdale, FL - 5/7/2007
• Pegaptanib Sodium (Macugen) For the Treatment of Macular Edema following Central Retinal Vein Occlusion (CRVO) 
  Baltimore, MD - 5/1/2007
• Treatment of Macular Edema following Central Retinal Vein Occlusion with Pegaptanib Sodium 
  Cape Town, South Africa - 10/16/2006
• Pegaptanib Sodium for the Treatment of Macular Edema following Central Retinal Vein Occlusion 
  Cannes, France - 9/12/2006
• Understanding Age-related Macular Degeneration 
  Columbia, SC - 10/16/2003
• Inferior Displacement of Submacular Hemorrhage 
  Jules Gonin, Lausanne, Switzerland - 9/1/2002
• Fundus Autofluorescence in Macular Diseases 
  New York City, NY - 6/1/2000
• Reticular Pseudodrusen in Age-related Macular Degeneration 
  Portsea, Victoria, Australia - 3/10/2000
• Vascular Endothelial Growth Factor/ Vascular Permeability Factor (VEGF/VPF) Levels Are Elevated in the Vitreous of Patients with Subretinal Neovascularization 
  Fort Lauderdale, FL - 5/1/1995
• Surgical Treatment of Full-thickness Macular Holes Using Autologous Serum 
  Birmingham - 5/1/1995
• The Vanishing Nucleus: Management of Dislocated Crystalline Lenses 
  London - 2/1/1995
• Laser Treatment of Retinal Disease 
  London - 2/1/1995
• Surgical Removal of Subfoveal Membranes 
  London - 1/1/1995
• Idiopathic Full-thickness Macular Holes 
  Moorfields Eye Hospital, London - 9/1/1994
• Join now to see all

Other

• Randomized Trial Evaluating Short-Term Effects of Intravitreal Ranibizumab or Triamcinolone Acetonide on Macular Edema Following Focal/Grid Laser for Diabetic Macular ... 
  Diabetic Retinopathy Clinical Research Network, Retina
  1/1/2011